Kansas City University Recognized for "Groundbreaking" Pancreatic Cancer Research
KANSAS CITY, Mo., Aug. 24, 2023 /PRNewswire/ -- Kansas City University (KCU) Associate professor Ehab Sarsour, MSc, PhD, and student-researchers have discovered a new and promising avenue for treating pancreatic cancer by treating the tumor microenvironment by repurposing a drug designed for hyperlipidemia.
- KANSAS CITY, Mo., Aug. 24, 2023 /PRNewswire/ -- Kansas City University (KCU) Associate professor Ehab Sarsour, MSc, PhD, and student-researchers have discovered a new and promising avenue for treating pancreatic cancer by treating the tumor microenvironment by repurposing a drug designed for hyperlipidemia.
- The research found that pancreatic cancer cells receive support from fatty acids that feed pancreatic cancer tumors and protect them from radiation and chemotherapy.
- As humans age, the risk of cancer increases due to metabolic change dependent on fatty acids and lipids Fatty acids help pancreatic tumor cells resist radiation and chemotherapy.
- "Katiana' s research work resulted in making cancer cells weaker, depriving them of nourishment from the microenvironment they were in that enables them to be resilient," said Sarsour.